Texier Thomas 4
4 · Marex Group plc · Filed May 5, 2026
Research Summary
AI-generated summary of this filing
Marex (MRX) Group Head of Clearing Thomas Texier Sells Shares
What Happened
Thomas Texier, Group Head of Clearing at Marex Group plc (MRX), sold a total of 14,427 ordinary shares in open-market transactions on May 1, 2026 for aggregate proceeds of approximately $764,488. The sales consisted of 11,821 shares at a weighted average price of $52.87 (proceeds $624,992) and 2,606 shares at a weighted average price of $53.53 (proceeds $139,496). The transactions were reported on Form 4 filed May 5, 2026.
Key Details
- Transaction date: May 1, 2026 (filed May 5, 2026). Form 4s are typically due within two business days of the trade; investors may want to note the filing date.
- Sale 1: 11,821 shares, weighted avg price $52.87, proceeds $624,992. Price range for these trades: $52.42 to $53.415. (Footnote F2)
- Sale 2: 2,606 shares, weighted avg price $53.53, proceeds $139,496. Price range for these trades: $53.42 to $53.72. (Footnote F3)
- Sales were effected pursuant to a Rule 10b5-1 plan entered September 10, 2025. (Footnote F1)
- Shares owned after the transaction: not specified in the filing. The form notes that reported holdings include 192,348 shares underlying deferred bonus awards previously granted to the reporting person (contingent rights to receive shares upon vesting). (Footnote F4)
- Transaction type: Sales (S) — generally considered routine disposition unless otherwise noted.
Context
The sales were made under a prearranged 10b5-1 plan, which is commonly used by insiders to sell shares at predetermined intervals and is generally treated as a routine liquidity event rather than a direct signal of management sentiment. For retail investors, purchases or acquisitions by insiders tend to be more informative about conviction; documented, preplanned sales like this primarily provide transparency about insider liquidity.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-05-01$52.87/sh−11,821$624,992→ 230,837 total - Sale
Ordinary Shares
[F1][F3][F4]2026-05-01$53.53/sh−2,606$139,496→ 228,231 total
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $52.42 to $53.415, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $53.42 to $53.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The number of ordinary shares reported herein includes 192,348 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.